REGULATION OF THE ANTIBODY RESPONSE TO MICROBIAL POLYSACCHARIDE ANTIGENS

微生物多糖抗原抗体反应的调节

基本信息

项目摘要

The immunomodulatory properties of several lipopolysaccharides (LPS) derived from clinical isolates of Pseudomonas aeruginosa, Branhamella catarrhalis, and Bordetella pertussis were evaluated for their capacity to influence the magnitude of the antibody response to type III pneumococcal polysaccharide (SSS-III), which is known to be regulated in a negative and positive manner by suppressor and amplifier T cells (Ts and Ta, respectively). The administration of LPS, two days after immunization result in a significant increase in the antibody response. Such enhancement appears to be due to the ability of the lipid A moiety of LPS to abolish the negative effects of activated Ts, thereby enabling Ta function to be more fully expressed. By contrast, treatment with LPS a the time of immunization with SSS-III-specific i.e., prior to the activation of Ts induces significant suppression of the SSS-III-specific antibody response, such suppression is independent of the capacity of LPS to activate B cells polyclonally, an activity generally attributed to the lipid A fraction of LPS. Studies conducted with LPS of P. aeruginosa indicated that the suppression induced is T-cell dependent and mediated by the polysaccharide (PS) fraction of LPS: it appears to be due - at least in part - to the capacity of PS to expand or increase the size of the precursor pool of Ts, activated in response to SSS-III. These findings suggest that the capacity of the PS fraction of LPS to augment Ts function may play an important role in the pathogenesis of certain gram-negative infections.
几种脂多糖(LPS)的免疫调节特性

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

P J BAKER其他文献

P J BAKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('P J BAKER', 18)}}的其他基金

GENETIC CONTROL OF THE ANTIBODY RESPONSE TO MICROBIAL ANTIGENS
对微生物抗原的抗体反应的遗传控制
  • 批准号:
    4688363
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC CONTROL OF THE ANTIBODY RESPONSE TO MICROBIAL ANTIGENS
对微生物抗原的抗体反应的遗传控制
  • 批准号:
    3803095
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF THE ANTIBODY RESPONSE TO MICROBIAL POLYSACCHARIDE ANTIGENS
微生物多糖抗原抗体反应的调节
  • 批准号:
    3821967
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC CONTROL OF THE ANTIBODY RESPONSE TO MICROBIAL ANTIGENS
对微生物抗原的抗体反应的遗传控制
  • 批准号:
    3818114
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MODE OF ACTION OF THYMUS DERIVED (T) SUPPRESSOR AND AMPLIFIER CELLS
胸腺源性 (T) 抑制细胞和增强细胞的作用方式
  • 批准号:
    3960451
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MODE OF ACTION OF THYMUS DERIVED (T) SUPPRESSOR AND AMPLIFIER CELLS
胸腺源性 (T) 抑制细胞和增强细胞的作用方式
  • 批准号:
    4688365
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MODE OF ACTION OF THYMUS DERIVED (T) SUPPRESSOR AND AMPLIFIER CELLS
胸腺源性 (T) 抑制细胞和增强细胞的作用方式
  • 批准号:
    3809557
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MODE OF ACTION OF THYMUS DERIVED (T) SUPPRESSOR AND AMPLIFIER CELLS
胸腺源性 (T) 抑制细胞和增强细胞的作用方式
  • 批准号:
    3790670
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF THE ANTIBODY RESPONSE TO MICROBIAL POLYSACCHARIDE ANTIGENS
微生物多糖抗原抗体反应的调节
  • 批准号:
    3803096
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC CONTROL OF THE ANTIBODY RESPONSE TO MICROBIAL ANTIGENS
对微生物抗原的抗体反应的遗传控制
  • 批准号:
    3821966
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia
研究百日咳博德特氏菌与呼吸道上皮细胞相互作用的气液界面系统
  • 批准号:
    10665943
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Identification of novel immunogenic proteins from Bordetella pertussis
百日咳博德特氏菌新型免疫原性蛋白的鉴定
  • 批准号:
    10306163
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Identification of novel immunogenic proteins from Bordetella pertussis
百日咳博德特氏菌新型免疫原性蛋白的鉴定
  • 批准号:
    10627863
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
  • 批准号:
    10375566
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussis
无细胞疫苗是否会导致缺乏百日咳博德特氏菌的增加
  • 批准号:
    10364771
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Protection against Bordetella pertussis transmission conferred by established and novel vaccines
现有疫苗和新型疫苗可预防百日咳博德特氏菌传播
  • 批准号:
    10194677
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Identification of novel immunogenic proteins from Bordetella pertussis
百日咳博德特氏菌新型免疫原性蛋白的鉴定
  • 批准号:
    10425440
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Human challenge model of Bordetella pertussis infection
百日咳博德特氏菌感染的人体攻击模型
  • 批准号:
    10016748
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
大规模 T 细胞表位发现:疫苗接种和自然感染中百日咳博德特氏菌 T 细胞表位的全基因组特征
  • 批准号:
    10616655
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
大规模 T 细胞表位发现:疫苗接种和自然感染中百日咳博德特氏菌 T 细胞表位的全基因组特征
  • 批准号:
    10439413
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了